Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC - Pasi A. Jänne; David Planchard; Kunihiko Kobayashi; James Chih-Hsin Yang; Ying Liu; Natalia Valdiviezo; Tae Min Kim; Liyan Jiang; Hiroshi Kagamu; Noriko Yanagitani; Jialei Wang; Bivas Biswas; et al. (New England Journal of Medicine, 2026)